<DOC>
	<DOCNO>NCT00394498</DOCNO>
	<brief_summary>Eighty-six patient heart attack identify hospital . Post heart attack assess heart function , blood flow heart , heart cell function . We assess parameter use nuclear cardiology scan use everyday cardiology practice . The patient divide 2 group . One group receive medication call G-CSF group receive placebo . We give drug ( 1-2ml ) 4 day beneath skin . We take patient blood time measure drug affect blood . The patient nuclear cardiology test 6 week 6 month see heart function . As well , six month angiogram . All patient otherwise receive optimal care Cardiologist . They see 6 , 12 , 24 , 52 week assess clinically . This study test effect G-CSF heart function patient heart attack . It medication show animal model improve heart function heart attack . It medication use many year treat patient cancer increase number cell donate healthy bone marrow donor . It serious side effect . It work increase number person â€™ stem cell blood . Stem cell special cell present body ability form new cell . It think heart could make new cell damage . Other investigator show might case . It think injury , stem cell bone marrow transform cell injured tissue . Therefore , try increase number stem cell circulation G-CSF increase repair heart damage . This strategy never try human being successful could greatly reduce death suffer heart disease .</brief_summary>
	<brief_title>Stem Cell Mobilization G-CSF Post Myocardial Infarction Promote Myocyte Repair</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>1 . Large anterior wall ST elevation AMI define : Post AMI LVEF le 45 % assessed echocardiography . It standard practice institution obtain echocardiograms patient day 4 post AMI . 2 . Age 40 75 year 3 . Angiographically patent infarct relate artery ( IRA ) TIMI 3 flow significant stenosis ( &gt; 70 % diameter stenosis nonintervened upon artery &gt; 30 % artery PTCA ) , dissection visible thrombus , consider low risk reocclusion Cardiologist perform coronary angiography . In patient undergone PTCA , assessment none post PTCA angiogram . This majority patient . 4 . Eligible treatment GCSF within 5 day Post AMI . 1 . Prior STEMI 2 . Patients regional wall motion abnormality noninfarct region 3 . Prior CABG need CABG 4 . Patients significant valve disease ; define stenosis regurgitation grade great moderate ( 2+ ) . 5 . Patients clinically apparent , concurrent infection , require intravenous antibiotic 6 . Patients could pregnant 7 . Patients another etiology LV dysfunction ( known/suspected non ischemic cardiomyopathy , previous anthracycline therapy , know ethanol abuse ( great 6 oz . ethanol/day regular basis ) .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Stem Cells</keyword>
</DOC>